SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-20-024770
Filing Date
2020-12-03
Accepted
2020-12-03 16:12:35
Documents
1
Period of Report
2020-12-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3420
  Complete submission text file 0001437749-20-024770.txt   5009
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Issuer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address
Schemel Donald Robert (Reporting) CIK: 0001652854 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39468 | Film No.: 201367047